關閉

1/5

關閉

1/4

華西醫(yī)學期刊出版社

《中國普外基礎與臨床雜志》

主管：中華人民共和國教育部主辦：四川大學華西醫(yī)院
主編：嚴律南
刊期：月刊 ISSN：1007-9424 CN：51-1505/R

微信公眾號

您的位置：中國普外基礎與臨床雜志  2010, 7  文章全文

下肢動脈閉塞性疾病腔內治療進展

來源期刊：中國普外基礎與臨床雜志 | 2010, 17(7): 645-648
網絡首發(fā)時間：

閱讀量：2700
下載量：543
被引用量：0

作者：

包俊敏

第二軍醫(yī)大學上海長海醫(yī)院血管外科（上海 200433）;

關鍵詞：

周圍動脈疾病腔內治療適應證經皮血管腔內成形術支架重癥肢體缺血

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 包俊敏. 下肢動脈閉塞性疾病腔內治療進展. 中國普外基礎與臨床雜志, 2010, 17(7): 645-648. doi: 復制

1.	Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASCⅡ) [J]. J Vasc Surg, 2007; 45 Suppl S: S5S67.
2.	Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review [J]. Cardiovasc Intervent Radiol, 2008; 31(4): 687697.
3.	Rückert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study [J]. J Vasc Surg, 2009; 49(5): 12031209.
4.	McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol selfexpanding stent graft vs prosthetic femoralpopliteal bypass in the treatment of superficial femoral artery occlusive disease [J]. J Vasc Surg, 2009; 49(1): 109116.
5.	Faglia E, Clerici G, Clerissi J, et al. Longterm prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study [J]. Diabetes Care, 2009; 32(5): 822827.
6.	Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease [J]. Nephrol Dial Transplant, 2007; 22(4): 11441149.
7.	Chew DK, Conte MS, Donaldson MC, et al. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction [J]. J Vasc Surg, 2001; 33(2): 259265.
8.	Faries PL, Arota S, Pomposelli FB Jr, et al. The use of arm vein in lowerextremity revascularization: results of 520 procedures performed in eight years [J]. J Vasc Surg, 2000; 31(1 Pt 1): 5059.
9.	Halloran BG, Lilly MP, Cohn EJ, et al. Tibial bypass using complex autologous conduit: patency and limb salvage [J]. Ann Vasc Surg, 2001; 15(6): 634643.
10.	Rabellino M, Zander T, Baldi S, et al. Clinical followup in endovascular treatment for TASC CD lesions in femoropopliteal segment [J]. Catheter Cardiovasc Interv, 2009; 73 (5): 701705.
11.	Donas KP, Schwindt A, Schnefeld T, et al. Belowknee bare nitinol stent placement in highrisk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice [J]. Eur J Vasc Endovasc Surg, 2009; 37(6): 688693.
12.	Ansel GM, Sample NS, Botti III CF Jr, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia [J]. Catheter Cardiovasc Interv, 2004; 61(1): 14.
13.	Engelke C, Sandhu C, Morgan RA, et al. Using 6mm Cutting Balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results [J]. AJR Am J Roentgenol, 2002; 179(3): 619623.
14.	Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection [J]. J Endovasc Ther, 2006; 13(5): 592602.
15.	McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions [J]. Ann Surg, 2008; 248(4): 519528.
16.	Saxon RR, Coffman JM, Gooding JM, et al. Longterm results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial [J]. J Vasc Interv Radiol, 2003; 14(3): 303311.
17.	Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft [J]. J Endovasc Ther, 2003; 10(3): 619628.
18.	Farraj N, Srivastava A, Pershad A. Oneyear outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft [J]. J Invasive Cardiol, 2009; 21(6): 278281.
19.	Deutschmann HA, Schedlbauer P, Bérczi V, et al. Placement of Hemobahn stentgrafts in femoropopliteal arteries: early experience and midterm results in 18 patients [J]. J Vasc Interv Radiol, 2001; 12(8): 943950.
20.	Duda SH, Poerner TC, Wiesinger B, et al. Drugeluting stents: potential applications for peripheral arterial occlusive disease [J]. J Vasc Interv Radiol, 2003; 14(3): 291301.
21.	Duda SH, Bosiers M, Lammer J, et al. Sirolimuseluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial [J]. J Vasc Interv Radiol, 2005; 16(3): 331338.
22.	Minar E, Schillinger M. New stents for SFA [J]. J Cardiovasc Surg (Torino), 2009; 50(5): 635645.
23.	Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting [J]. Circulation, 2007; 115(21): 27452749.
24.	Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimuseluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6month angiographic results from a nonrandomized prospective singlecenter study [J]. J Endovasc Ther, 2005; 12(6): 685695.
25.	Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimuseluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1year angiographic and clinical benefit [J]. J Endovasc Ther, 2007; 14(2): 241250.
26.	Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues [J]. J Endovasc Ther, 2009; 16 Suppl Ⅰ: Ⅰ153 Ⅰ162.
27.	Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4F selfexpanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia [J]. J Vasc Interv Radiol, 2007; 18(6): 703708.
28.	王玉琦, 史振宇. 我國血管外科的現(xiàn)狀與展望 [J]. 中國普外基礎與臨床雜志, 2008; 15(6): 387389.

1. Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASCⅡ) [J]. J Vasc Surg, 2007; 45 Suppl S: S5S67.
2. Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review [J]. Cardiovasc Intervent Radiol, 2008; 31(4): 687697.
3. Rückert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study [J]. J Vasc Surg, 2009; 49(5): 12031209.
4. McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol selfexpanding stent graft vs prosthetic femoralpopliteal bypass in the treatment of superficial femoral artery occlusive disease [J]. J Vasc Surg, 2009; 49(1): 109116.
5. Faglia E, Clerici G, Clerissi J, et al. Longterm prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study [J]. Diabetes Care, 2009; 32(5): 822827.
6. Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease [J]. Nephrol Dial Transplant, 2007; 22(4): 11441149.
7. Chew DK, Conte MS, Donaldson MC, et al. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction [J]. J Vasc Surg, 2001; 33(2): 259265.
8. Faries PL, Arota S, Pomposelli FB Jr, et al. The use of arm vein in lowerextremity revascularization: results of 520 procedures performed in eight years [J]. J Vasc Surg, 2000; 31(1 Pt 1): 5059.
9. Halloran BG, Lilly MP, Cohn EJ, et al. Tibial bypass using complex autologous conduit: patency and limb salvage [J]. Ann Vasc Surg, 2001; 15(6): 634643.
10. Rabellino M, Zander T, Baldi S, et al. Clinical followup in endovascular treatment for TASC CD lesions in femoropopliteal segment [J]. Catheter Cardiovasc Interv, 2009; 73 (5): 701705.
11. Donas KP, Schwindt A, Schnefeld T, et al. Belowknee bare nitinol stent placement in highrisk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice [J]. Eur J Vasc Endovasc Surg, 2009; 37(6): 688693.
12. Ansel GM, Sample NS, Botti III CF Jr, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia [J]. Catheter Cardiovasc Interv, 2004; 61(1): 14.
13. Engelke C, Sandhu C, Morgan RA, et al. Using 6mm Cutting Balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results [J]. AJR Am J Roentgenol, 2002; 179(3): 619623.
14. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection [J]. J Endovasc Ther, 2006; 13(5): 592602.
15. McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions [J]. Ann Surg, 2008; 248(4): 519528.
16. Saxon RR, Coffman JM, Gooding JM, et al. Longterm results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial [J]. J Vasc Interv Radiol, 2003; 14(3): 303311.
17. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft [J]. J Endovasc Ther, 2003; 10(3): 619628.
18. Farraj N, Srivastava A, Pershad A. Oneyear outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft [J]. J Invasive Cardiol, 2009; 21(6): 278281.
19. Deutschmann HA, Schedlbauer P, Bérczi V, et al. Placement of Hemobahn stentgrafts in femoropopliteal arteries: early experience and midterm results in 18 patients [J]. J Vasc Interv Radiol, 2001; 12(8): 943950.
20. Duda SH, Poerner TC, Wiesinger B, et al. Drugeluting stents: potential applications for peripheral arterial occlusive disease [J]. J Vasc Interv Radiol, 2003; 14(3): 291301.
21. Duda SH, Bosiers M, Lammer J, et al. Sirolimuseluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial [J]. J Vasc Interv Radiol, 2005; 16(3): 331338.
22. Minar E, Schillinger M. New stents for SFA [J]. J Cardiovasc Surg (Torino), 2009; 50(5): 635645.
23. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting [J]. Circulation, 2007; 115(21): 27452749.
24. Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimuseluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6month angiographic results from a nonrandomized prospective singlecenter study [J]. J Endovasc Ther, 2005; 12(6): 685695.
25. Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimuseluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1year angiographic and clinical benefit [J]. J Endovasc Ther, 2007; 14(2): 241250.
26. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues [J]. J Endovasc Ther, 2009; 16 Suppl Ⅰ: Ⅰ153 Ⅰ162.
27. Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4F selfexpanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia [J]. J Vasc Interv Radiol, 2007; 18(6): 703708.
28. 王玉琦, 史振宇. 我國血管外科的現(xiàn)狀與展望 [J]. 中國普外基礎與臨床雜志, 2008; 15(6): 387389.

{picture}

{title}



下載CSV 下載原圖下載幻燈片

點擊下面內容復制并粘貼一種已設定好的引用格式。

引用本文： 包俊敏. 下肢動脈閉塞性疾病腔內治療進展. 中國普外基礎與臨床雜志, 2010, 17(7): 645-648. doi:

Format

RIS
BibTex
Text

Content

引文
引文和摘要